FP
FLGT icon

Financial Perspectives’s Fulgent Genetics FLGT Stock Holding History

Financial Perspectives’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11
Closed -$419 – 695
2022
Q3 		$419 Hold
11
– – ﹤0.01% 658
2022
Q2 		$600 Hold
11
– – ﹤0.01% 646
2022
Q1 		$687 Hold
11
– – ﹤0.01% 649
2021
Q4 		$1.11K Buy
+11
New +$967 ﹤0.01% 608

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Financial Perspectives's FLGT Position: Q4 2022 in Review

Financial Perspectives sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 11 shares — an estimated $419 sold.

Financial Perspectives first reported a position in FLGT in Q4 2021 and held it in 4 quarters. The position peaked at $1.11K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Financial Perspectives reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Financial Perspectives sold 11 Fulgent Genetics shares in Q4 2022, an estimated $419.
  • Financial Perspectives first reported a position in Fulgent Genetics in Q4 2021 and held it in 4 quarters.
  • Financial Perspectives's Fulgent Genetics position peaked at $1.11K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Financial Perspectives's 13F filing for Q4 2022, filed 10 Jan 2024.